Dopamine enhances fast excitatory synaptic transmission in the extended amygdala by a CRF-R1-dependent process
Open accessAbstract
A common feature of drugs of abuse is their ability to increase extracellular dopamine levels in key brain circuits. The actions of dopamine within these circuits are thought to be important in reward and addiction-related behaviors. Current theories of addiction also posit a central role for corticotrophin-releasing factor (CRF) and an interaction between CRF and monoaminergic signaling. One region where drugs of abuse promote robust rises in extracellular dopamine levels is the bed nucleus of the stria terminalis (BNST), a CRF-rich component of the extended amygdala. We find that dopamine rapidly enhances glutamatergic transmission in the BNST through activation of a combination of D(1)- and D(2)-like receptors. This enhancement is activity-dependent and requires the downstream action of CRF receptor 1 (CRF-R1), suggesting that dopamine induces CRF release through a local network mechanism. Furthermore, we found that both in vivo and ex vivo cocaine induced a dopamine receptor and CRF-R1-dependent enhancement of a form of NMDA receptor-dependent short-term potentiation in the BNST. These data highlight a direct and rapid interaction between dopamine and CRF systems that regulates excitatory transmission and plasticity in a brain region key to reinforcement and reinstatement. Because a rise in extracellular dopamine levels in the BNST is a shared consequence of multiple classes of drugs of abuse, this suggests that the CRF-R1-dependent enhancement of glutamatergic transmission in this region may be a common key feature of substances of abuse.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
DA receptor signaling in the BNST and CeA modulates synaptic transmission and activity.
“DA receptor signaling in these regions modulates synaptic transmission and activity (Kash et al., 2008, de la Mora et al., 2010).”
From Dorsal raphe dopamine neurons represent the experience of social isolation (2016) · cites this paper as Kash et al., 2008
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Vaughan, J. M., Donaldson, C. J., Bittencourt, J. C., Perrin, M. H., Lewis, K., Sutton, S. W., Chan, R. K. W., Turnbull, A. V., Lovejoy, D. A., RIVIER, C. L., et al. (1995) · Nature · doi:10.1038/378287a0 · Cited by 1,479 · see citing works
Synaptic plasticity and addiction
Kauer, J. A., & Malenka, R. C. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2234 · Cited by 1,397 · see citing works
Single cocaine exposure in vivo induces long-term potentiation in dopamine neurons
Ungless, M. A., Whistler, J. L., Malenka, R. C., & Bonci, A. (2001) · Nature · doi:10.1038/35079077 · Cited by 1,106 · see citing works
Role of the bed nucleus of the stria terminalis versus the amygdala in fear, stress, and anxiety
Walker, D. L., Toufexis, D. J., & Davis, M. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01282-2 · Cited by 838 · see citing works
Borgland, S. L., Taha, S. A., Sarti, F., Fields, H. L., & Bonci, A. (2006) · Neuron · doi:10.1016/j.neuron.2006.01.016 · Cited by 718 · see citing works
Thomas, M. J., Beurrier, C., Bonci, A., & Malenka, R. C. (2001) · Nature Neuroscience · doi:10.1038/nn757 · Cited by 629 · see citing works
Bidirectional dopamine modulation of GABAergic inhibition in prefrontal cortical pyramidal neurons
Seamans, J. K., Gorelova, N., Durstewitz, D., & Yang, C. R. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03628.2001 · Cited by 507 · see citing works
Role of Corticotropin-Releasing Factor in Drug Addiction
Logrip, M. L., Koob, G. F., & Zorrilla, E. P. (2011) · CNS Drugs · doi:10.2165/11587790-000000000-00000 · Cited by 474 · see citing works
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion
Delfs, J. M., Zhu, Y., Druhan, J. P., & Aston-Jones, G. (2000) · Nature · doi:10.1038/35000212 · Cited by 462 · see citing works
Valjent, E., Pagès, C., Hervé, D., Girault, J., & Caboche, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03278.x · Cited by 434 · see citing works
Choi, D. C., Furay, A. R., Evanson, N. K., Ostrander, M. M., Ulrich-Lai, Y. M., & Herman, J. P. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.4301-06.2007 · Cited by 392 · see citing works
The Role of Corticotropin-Releasing Factor in Drug Addiction
Sarnyai, Z., Shaham, Y., & Heinrichs, S. C. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01492-3 · Cited by 381 · see citing works
Dong, H., & Swanson, L. W. (2003) · The Journal of Comparative Neurology · doi:10.1002/cne.10949 · Cited by 347 · see citing works
Cortical afferents to the extended amygdala
McDONALD, A. J., SHAMMAH‐LAGNADO, S. J., SHI, C., & DAVIS, M. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09275.x · Cited by 306 · see citing works
Ungless, M. A., Singh, V., Crowder, T. L., Yaka, R., Ron, D., & Bonci, A. (2003) · Neuron · doi:10.1016/s0896-6273(03)00461-6 · Cited by 297 · see citing works
Georges, F. E., & Aston‐Jones, G. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-12-05173.2002 · Cited by 287 · see citing works
Ethanol Augments GABAergic Transmission in the Central Amygdala via CRF1 Receptors
Nie, Z., Schweitzer, P., Roberts, A. J., Madamba, S. G., Moore, S. D., & Siggins, G. R. (2004) · Science · doi:10.1126/science.1092550 · Cited by 267 · see citing works
D1 and D2 dopamine receptor mRNA expression in whole hemisphere sections of the human brain
Hurd, Y. L., Suzuki, M., & Sedvall, G. C. (2001) · Journal of Chemical Neuroanatomy · doi:10.1016/s0891-0618(01)00122-3 · Cited by 262 · see citing works
Wanat, M. J., Hopf, F. W., Stuber, G. D., Phillips, P. E. M., & Bonci, A. (2008) · The Journal of Physiology · doi:10.1113/jphysiol.2007.150078 · Cited by 256 · see citing works
Walker, D. L., & Davis, M. (2008) · Brain Structure and Function · doi:10.1007/s00429-008-0183-3 · Cited by 231 · see citing works
A Neurochemically Distinct Dorsal Raphe-Limbic Circuit with a Potential Role in Affective Disorders
Commons, K. G., Connolley, K. R., & Valentino, R. J. (2002) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300045 · Cited by 211 · see citing works
Blank, T., Nijholt, I. M., Eckart, K., & Spiess, J. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-09-03788.2002 · Cited by 210 · see citing works
Dopamine Modulates Excitability of Basolateral Amygdala Neurons In Vitro
Kröner, S., Rosenkranz, J. A., Grace, A. A., & Barrionuevo, G. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00843.2004 · Cited by 202 · see citing works
Rodaros, D., Caruana, D. A., Amir, S., & Stewart, J. (2007) · Neuroscience · doi:10.1016/j.neuroscience.2007.09.043 · Cited by 194 · see citing works
Carboni, E., Silvagni, A., Rolando, M. T. P., & Chiara, G. D. (2000) · Journal of Neuroscience · doi:10.1523/jneurosci.20-20-j0002.2000 · Cited by 171 · see citing works
Laviolette, S. R., & Grace, A. A. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6027-5 · Cited by 170 · see citing works
Comparison of the distribution of D-1 and D-2 dopamine receptors in the rat brain.
Wamsley, J. K., Gehlert, D. R., Filloux, F. M., & Dawson, T. M. (1989) · PubMed · Cited by 168 · see citing works
Justice, N. J., Yuan, Z. F., Sawchenko, P. E., & Vale, W. (2008) · The Journal of Comparative Neurology · doi:10.1002/cne.21848 · Cited by 167 · see citing works
Kash, T. L., & Winder, D. G. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.06.011 · Cited by 166 · see citing works
Self-citationNavakkode, S., Sajikumar, S., & Frey, J. U. (2007) · Neuropharmacology · doi:10.1016/j.neuropharm.2007.02.010 · Cited by 149 · see citing works
Hopf, F. W., Cascini, M. G., Gordon, A. S., Diamond, I., & Bonci, A. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-12-05079.2003 · Cited by 146 · see citing works
Chen, Dagnino, R., Souza, E. B. D., et al. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm960149e · Cited by 137 · see citing works
Liu, J., Yu, B., Neugebauer, V., Grigoriadis, D. E., Rivier, J., Vale, W., Shinnick‐Gallagher, P., & Gallagher, J. P. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.5531-03.2004 · Cited by 134 · see citing works
Gao, C., Sun, X., & Wolf, M. E. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.03999.x · Cited by 132 · see citing works
Epping-Jordan, M. P., Markou, A., & Koob, G. F. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01190-6 · Cited by 131 · see citing works
CRF1 receptor antagonists attenuate escalated cocaine self-administration in rats
Specio, S. E., Wee, S., O’Dell, L. E., Boutrel, B., Zorrilla, E. P., & Koob, G. F. (2007) · Psychopharmacology · doi:10.1007/s00213-007-0983-9 · Cited by 129 · see citing works
Hammack, S. E., Mania, I., & Rainnie, D. G. (2007) · Journal of Neurophysiology · doi:10.1152/jn.00382.2007 · Cited by 128 · see citing works
So, C. H., Varghese, G. K., Curley, K. J., Kong, M. M. C., Alijaniaram, M., Ji, X., Nguyen, T., O’Dowd, B. F., & George, S. R. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.012229 · Cited by 116 · see citing works
Dopamine decreases the calcium-activated afterhyperpolarization in hippocampal CA1 pyramidal cells
Malenka, R. C., & Nicoll, R. A. (1986) · Brain Research · doi:10.1016/0006-8993(86)90773-0 · Cited by 114 · see citing works
Meloni, E. G., Gerety, L. P., Knoll, A. T., Cohen, B. M., & Carlezon, W. A. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.4957-05.2006 · Cited by 109 · see citing works
Eiler, W. J. A., Seyoum, R., Foster, K. L., Mailey, C., & June, H. L. (2003) · Synapse · doi:10.1002/syn.10181 · Cited by 98 · see citing works
CRF Facilitates Calcium Release from Intracellular Stores in Midbrain Dopamine Neurons
Riegel, A. C., & Williams, J. T. (2008) · Neuron · doi:10.1016/j.neuron.2007.12.029 · Cited by 97 · see citing works
Stanwood, G. D., Parlaman, J. P., & Levitt, P. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04970.x · Cited by 92 · see citing works
Phelix, C. F., Liposits, Z., & Willis, K. P. (1994) · Brain Research Bulletin · doi:10.1016/0361-9230(94)90056-6 · Cited by 87 · see citing works
Levita, L., Hammack, S. E., Mania, I., Li, X.-Y., Davis, M., & Rainnie, D. G. (2004) · Neuroscience · doi:10.1016/j.neuroscience.2004.06.037 · Cited by 79 · see citing works
Grueter, B. A., & Winder, D. G. (2005) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300672 · Cited by 78 · see citing works
Self-citationWeitlauf, C., Egli, R. E., Grueter, B. A., & Winder, D. G. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.1181-04.2004 · Cited by 77 · see citing works
Self-citationEgli, R. E., & Winder, D. G. (2003) · Journal of Neurophysiology · doi:10.1152/jn.00228.2003 · Cited by 72 · see citing works
Self-citationPietro, N. C. D., & Seamans, J. K. (2007) · Pharmacopsychiatry · doi:10.1055/s-2007-992133 · Cited by 72 · see citing works
Alcohol Inhibits NR2B-Containing NMDA Receptors in the Ventral Bed Nucleus of the Stria Terminalis
Kash, T. L., Matthews, R. T., & Winder, D. G. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301504 · Cited by 71 · see citing works
Self-citationDopamine‐dependent responses to cocaine depend on corticotropin‐releasing factor receptor subtypes
Lü, L., Liu, Z., Huang, M., & Zhang, Z. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01635.x · Cited by 70 · see citing works
Fu, Y., Pollandt, S., Liu, J., Krishnan, B., Genzer, K. M., Orozco-Cabal, L. F., Gallagher, J. P., & Shinnick‐Gallagher, P. (2006) · Journal of Neurophysiology · doi:10.1152/jn.00349.2006 · Cited by 68 · see citing works
Cocaine-induced modulation of long-term potentiation in the CA1 region of rat hippocampus
THOMPSON, A., Swant, J., & Wagner, J. J. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.03.005 · Cited by 67 · see citing works
Pastor, R., McKinnon, C. S., Scibelli, A. C., Burkhart‐Kasch, S., Reed, C. L., Ryabinin, A. E., Coste, S. C., Stenzel‐Poore, M. P., & Phillips, T. J. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710181105 · Cited by 63 · see citing works
Wu, J., & Hablitz, J. J. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.1405-05.2005 · Cited by 55 · see citing works
Orozco-Cabal, L. F., Liu, J., Pollandt, S., Schmidt, K., Shinnick‐Gallagher, P., & Gallagher, J. P. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.2666-07.2008 · Cited by 46 · see citing works
Healey, J. C., Winder, D. G., & Kash, T. L. (2008) · Alcohol · doi:10.1016/j.alcohol.2008.01.003 · Cited by 42 · see citing works
Self-citationEnhancement of the acoustic startle response in rats by the dopamine D 1 receptor agonist SKF 82958
Meloni, E. G., & Davis, M. (1999) · Psychopharmacology · doi:10.1007/s002130051020 · Cited by 41 · see citing works
Rainnie, D. G. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09304.x · Cited by 40 · see citing works
Day, H. E. W., Curran, E. J., Watson, S. J., & Akil, H. (1999) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19991011)413:1
Flagged first, then by citations
Cited by
Sorted by citations
Dorsal raphe dopamine neurons represent the experience of social isolation
Matthews, G. A., Nieh, E. H., Vander Weele, C. M., Halbert, S. A., Pradhan, R. V., Yosafat, A. S., Glober, G. F., Izadmehr, E. M., Thomas, R. E., Lacy, G. D., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.040 · Cited by 402 · see citing works
Walker, D. L., Miles, L. A., & Davis, M. (2009) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2009.06.022 · Cited by 331 · see citing works
Neural mechanisms of social homeostasis
Matthews, G. A., & Tye, K. M. (2019) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14016 · Cited by 273 · see citing works
Functional heterogeneity in the bed nucleus of the stria terminalis
Gungor, N. Z., & Pare, D. (2016) · Journal of Neuroscience · doi:10.1523/jneurosci.0856-16.2016 · Cited by 214 · see citing works
Neurobiology of dysregulated motivational systems in drug addiction
Edwards, S., & Koob, G. F. (2010) · Future Neurology · doi:10.2217/fnl.10.14 · Cited by 157 · see citing works
Li, C., Sugam, J. A., Lowery-Gionta, E. G., McElligott, Z. A., McCall, N. M., Lopez, A. J., McKlveen, J. M., Pleil, K. E., & Kash, T. L. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.12 · Cited by 161 · see citing works
Self-citationSilberman, Y., Matthews, R. T., & Winder, D. G. (2013) · The Journal of Neuroscience · doi:10.1523/jneurosci.2949-12.2013 · Cited by 144 · see citing works
Self-citationde Guglielmo, G., Kallupi, M., Pomrenze, M. B., Crawford, E., Simpson, S., Schweitzer, P., Koob, G. F., Messing, R. O., & George, O. (2019) · Nature Communications · doi:10.1038/s41467-019-09183-0 · Cited by 127 · see citing works
Rutherford, H. J. V., Williams, S. K., Moy, S., Mayes, L. C., & Johns, J. M. (2011) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2011.00037 · Cited by 140 · see citing works
Stamatakis, A. M., Sparta, D. R., Jennings, J. H., McElligott, Z. A., Decot, H., & Stuber, G. D. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.05.046 · Cited by 132 · see citing works
Buffalari, D. M., & See, R. E. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2008-3 · Cited by 87 · see citing works
Hu, P., Liu, J., Maita, I., Kwok, C., Gu, E., Gergues, M. M., Kelada, F., Phan, M., Zhou, J.-N., Swaab, D. F., et al. (2020) · The Journal of Neuroscience · doi:10.1523/jneurosci.2410-19.2020 · Cited by 71 · see citing works
Conrad, K. L., Louderback, K. M., Gessner, C. P., & Winder, D. G. (2011) · Physiology & Behavior · doi:10.1016/j.physbeh.2011.03.001 · Cited by 71 · see citing works
The role of biogenic amine signaling in the bed nucleus of the stria terminals in alcohol abuse
Kash, T. L. (2012) · Alcohol · doi:10.1016/j.alcohol.2011.12.004 · Cited by 58 · see citing works
“In keeping with the DA CRF interaction, work from the Winder lab found that dopamine lead to a CRFdependent increase in glutamate release in the BNST, providing a mechanism by which dopamine can influence CRF signaling on a circuit scale (Kash et al., 2008).”
Self-citation
- Authors
- Kash, T. L., Nobis, W. P., Matthews, R. T., & Winder, D. G.
- Affiliations
- Vanderbilt University (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2008-12-17
- Volume
- 28
- Issue
- 51
- Pages
- 13856-13865
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC2630395
- OpenAlex
- W2095210029
- Cited by
- 125
- References
- 60
- Citations by year
- 2025: 6 · 2023: 7 · 2022: 4 · 2021: 11 · 2020: 5 · 2019: 6 · 2018: 8 · 2017: 6 · 2016: 7 · 2015: 10 · 2014: 5 · 2013: 11 · 2012: 9
- FWCI
- 4.32
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (AA13641, AA017668)
- National Institute on Alcohol Abuse and Alcoholism (U01AA013641, F32AA016025, AA13641, R01AA019455, K99AA017668, AA017668, AA016025, R00AA017668, U01AA015635, U24AA013641)
- National Institute on Drug Abuse (DA 19112, R01DA019112)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- dopamine, corticotropin-releasing factor, CRF1 receptor, bed nucleus of the stria terminalis, extended amygdala, glutamatergic neurotransmission, dopamine D1 receptor, dopamine D2 receptor, cocaine, drug addiction, activity-dependent plasticity, monoaminergic signaling
- MeSH terms
- CRF Receptor, Type 1, Amygdala, Animals, Cocaine, Corticotropin-Releasing Hormone, Dopamine, Male, Mice, Inbred C57BL, Mice, Transgenic, Synaptic Transmission, Neuronal Plasticity, Organ Culture Techniques, Septal Nuclei, Illicit Drugs, Receptors, Dopamine D1, Receptors, Dopamine D2, Receptors, Corticotropin-Releasing Hormone, Patch-Clamp Techniques, Glutamic Acid, Excitatory Postsynaptic Potentials, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review